Used in research for inflammatory diseases due to its ability to inhibit p38 MAP kinase, a key protein involved in the production of pro-inflammatory cytokines. It has shown potential in studies related to rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and other conditions driven by inflammation. Its application remains primarily in preclinical and clinical development stages, focusing on modulating immune response and reducing tissue damage caused by excessive inflammation.